Your browser is out of date. It has known security flaws and may not display all features of this and other websites. Learn how to update your browser.
Lucozade originated in 1927 as the culmination of Newcastle chemist William Owen's efforts to create a source of energy for those who were sick with common illnesses. "Glucozade" was renamed Lucozade in 1929. On 9 September 2013, both Lucozade and Ribena were acquired from GlaxoSmithKline by the Japanese conglomerate Suntory for £1.35 billion.